ONCO
Price:
$0.62
Market Cap:
$353.88K
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cinci...[Read more]
Industry
Biotechnology
IPO Date
2022-02-18
Stock Exchange
NASDAQ
Ticker
ONCO
According to Onconetix, Inc.’s latest financial reports and current stock price. The company's current ROE is -189.85%. This represents a change of 67.38% compared to the average of -113.42% of the last 4 quarters.
The mean historical ROE of Onconetix, Inc. over the last ten years is -53.66%. The current -189.85% ROE has changed 253.83% with respect to the historical average. Over the past ten years (40 quarters), ONCO's ROE was at its highest in in the December 2023 quarter at 398.98%. The ROE was at its lowest in in the December 2024 quarter at -306.31%.
Average
-53.66%
Median
-59.94%
Minimum
-610.69%
Maximum
667.79%
Discovering the peaks and valleys of Onconetix, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 599.16%
Maximum Annual ROE = 667.79%
Minimum Annual Increase = -1214.06%
Minimum Annual ROE = -610.69%
| Year | ROE | Change |
|---|---|---|
| 2025 | -89.01% | -85.42% |
| 2024 | -610.69% | -191.45% |
| 2023 | 667.79% | -1214.06% |
| 2022 | -59.94% | -74.63% |
| 2021 | -236.24% | 599.16% |
| 2020 | -33.79% | 146.59% |
The current ROE of Onconetix, Inc. (ONCO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.64%
5-year avg
-65.62%
10-year avg
-53.66%
Onconetix, Inc.’s ROE is greater than Jasper Therapeutics, Inc. (-261.95%), greater than Azitra, Inc. (-344.59%), less than Revelation Biosciences, Inc. (-0.40%), greater than Scinai Immunotherapeutics Ltd. (-89.26%), greater than SciSparc Ltd. (-330.17%), greater than Indaptus Therapeutics, Inc. (-938.75%), greater than Enveric Biosciences, Inc. (-349.10%), greater than Silexion Therapeutics Ltd. (-387.82%), less than Protagenic Therapeutics, Inc. (153.29%), greater than Salarius Pharmaceuticals, Inc. (-401.03%),
| Company | ROE | Market cap |
|---|---|---|
| -261.95% | $19.99M | |
| -344.59% | $3.04M | |
| -0.40% | $1.76M | |
| -89.26% | $930.75K | |
| -330.17% | $267.80K | |
| -938.75% | $2.98M | |
| -349.10% | $1.22M | |
| -387.82% | $684.38K | |
| 153.29% | $1.28M | |
| -401.03% | $4.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconetix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Onconetix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Onconetix, Inc.'s ROE?
How is the ROE calculated for Onconetix, Inc. (ONCO)?
What is the highest ROE for Onconetix, Inc. (ONCO)?
What is the 3-year average ROE for Onconetix, Inc. (ONCO)?
What is the 5-year average ROE for Onconetix, Inc. (ONCO)?
How does the current ROE for Onconetix, Inc. (ONCO) compare to its historical average?